Quest Diagnostics (NYSE:DGX) faced headwinds after Medicare cut testing service rates. To counteract this government mandate, Quest expanded relationships with hospital systems and diversified via acquisitions. The company gained +10% in the quarter.
From Bernard Horn (Trades, Portfolio)'s Polaris Global Value Fund 2nd quarter 2018 shareholder letter.